ADARx Pharmaceuticals Funding & Investors

San Diego, CA

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

Total Amount Raised: $332,000,000

ADARx Pharmaceuticals Funding Rounds

Series C
$200,000,000
Aug 8, 2023
Series C Investors
Sr One
Lilly Asia Ventures
Bain Capital Life Sciences
Ascenta Capital
Marshall Wace
Venrock Healthcare Capital Partners
BlackRock
HBM Healthcare Investments
Redmile Group
Invus Group
Vivo Capital
Cormorant Asset Management
OrbiMed Advisors
TCG Crossover
T. Rowe Price
Commodore Capital
Series B
$46,000,000
Jan 19, 2023
Series B Investors
Sr One
Sirona Capital
Lilly Asia Ventures
Ascenta Capital
OrbiMed Advisors
Series B
$75,000,000
Sep 7, 2021
Series B Investors
Sr One
Sirona Capital
Lilly Asia Ventures
OrbiMed Advisors
Series Unknown
$6,000,000
Nov 11, 2020
Series Unknown
$5,000,000
Aug 3, 2020

Funding info provided by Diffbot.